OR WAIT null SECS
October 06, 2023
Biosynth has further strengthened its peptide division with the acquisition of Pepceuticals.
The BioIndustry Association reports that with a strong foundation in research and development in mRNA the United Kingdom will be a major player in this rapidly growing industry.
October 05, 2023
The Japanese biotech company plans to make good use of Orchard’s portfolio, furthering its goal of providing life-changing medical care through cell and gene therapy.
With the acquisition, Sharp plans on offering fully integrated small-to-medium scale sterile injectable services.
Clene was awarded the four-year grant for the National Institute of Neurological Disorders and Stroke to support an Expanded Access Protocol for ALS drug.
POINT is a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies in development for the treatment of cancer.
The program will allow sponsors of certain CBER and/or CDER-regulated products more frequent communication with FDA staff.
October 04, 2023
The prize was awarded jointly to Katalin Karikó and Drew Weissman for their groundbreaking discovery regarding modification of the bases in mRNA.
EMS is a leader in the cleanroom industry, delivering complete cleanroom monitoring and control solutions, services to customers, and ensuring quality by design from inception to process control.
Pfizer has entered into a collaboration with Ginkgo Bioworks to discover novel RNA molecules across priority research areas.